Europe
U.S. firm Abbott to buy Russian drugmaker for up to $495 million
U.S. healthcare firm Abbott Laboratories (ABT.N) is to buy Russian drugmaker Veropharm (VRPH.MM) for up to $495 million, giving it a manufacturing presence in a country where it has been operating for nearly 40 years, Abbott said on Tuesday.
Orange tops French mobile quality review, Free lags
France's largest carrier Orange topped an annual quality review of mobile services carried out by the country's telecoms regulator, while Iliad's Free Mobile lagged competitors.
Russia asks Twitter to block a dozen accounts
Russia asked Twitter on Monday to block access to a dozen accounts it deems "extremist", the head of the country's telecoms watchdog said, as Moscow seeks greater control over Internet sites based beyond its borders.
U.S. court rejects Gemalto's Android patent lawsuit
Gemalto NV, the French digital security company, said on Friday that the U.S. Court of Appeals for the Federal Circuit rejected its patent claim relating to the Android smart phone operating platform.